Autoimmune diseases

No definition available.

Endpoint definition

Name AUTOIMMUNE
Long name Autoimmune diseases
Include M13_RHEUMA, M13_RELAPSPOLYCHONDR, SLE_FG, M13_SJOGREN, M13_SYSTSLCE, M13_DERMATOPOLY, M13_WEGENER, M13_MICROPOLYANG, M13_CHURGSTRAUSS, D3_ALLERGPURPURA, I9_RHEUFEV, E4_HYTHY_AI_STRICT, G6_MS, E4_DM1, G6_ADEM, G6_DISSOTH, G6_NARCOCATA, AUTOIMMUNE_HYPERTHYROIDISM, E4_THYROIDITAUTOIM, E4_AUTOPOLYFAI, AUTOHEP, D3_AIHA_DRUG, D3_AIHA_OTHER, G6_MYASTHENIA, H7_OPTNEURITIS, G6_OTHDEMYEL, G6_MYOMUSCINOTH, K11_COELIAC, CHIRBIL_PRIM, G6_GUILBAR
First defined in version DF5

Summary Statistics

Key figures

All Female Male
Number of individuals 42202 30387 11815
Unadjusted prevalence (%) 19.45 24.74 12.55
Mean age at first event (years) 48.33 48.09 48.94
Case fatality at 5-years (%) 1.95 1.22 3.83

Longitudinal metrics

All Female Male
Median nb. of events per indiv. 20.0 23.0 13.0
Recurrence at 6 months (%) 84.73 87.12 78.58

Survival analyses between endpoints

Plot

before Autoimmune diseases
after Autoimmune diseases

Loading survival analyses plot…

Drugs most likely to be purchased after Autoimmune diseases